Minjia WangAnalytical Development Scientist II at Prime Medicine, Inc.Speaker
Agenda Sessions
Leveraging Platform-Based, Multi-Attribute LC Assays to Characterize Multi-components Prime Editing (PE) RNA-LNP
, 2:15pmView Session
